Peptide Injections AI
Slu-Pp-332 peptide therapy
Weight Loss & MetabolicEmerging Evidence

Slu-Pp-332 Peptide Therapy

Benefits, Side Effects, Cost & Protocols

SLU-PP-332 is a synthetic ERR-alpha/gamma agonist that acts as an exercise mimetic. It has demonstrated the ability to activate metabolic pathways normally triggered by physical exercise, including increased mitochondrial biogenesis, fat oxidation, and muscle fiber adaptation.

ByChris Riley(CFA)&Alex Evans, PharmD, MBA(PharmD, MBA)|Updated

Clinically Reviewed

Reviewed by Alex Evans, PharmD, MBA · Updated May 2026

Evidence-Based

Sourced from FDA, PubMed & ClinicalTrials.gov · View sources

FDA Status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Emerging Evidence
Category
Weight Loss & Metabolic

How Slu-Pp-332 Works

ERR (estrogen-related receptor) agonist that may activate exercise-like metabolic pathways and improve endurance.

Slu-Pp-332 FAQ

What is SLU-PP-332?

SLU-PP-332 is an emerging ERRα agonist being researched as an 'exercise mimetic' that may provide some benefits of exercise without physical activity.

How does SLU-PP-332 work?

ERR (estrogen-related receptor) agonist that may activate exercise-like metabolic pathways and improve endurance.

Is SLU-PP-332 legal to buy?

SLU-PP-332 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy SLU-PP-332?

SLU-PP-332 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does SLU-PP-332 belong to?

SLU-PP-332 is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.

What are the research benefits of SLU-PP-332?

SLU-PP-332 has been studied for: Exercise mimetic, Endurance research, Metabolic activation. ERR agonist; exercise pill research.

Key Studies

10 total on PubMed0

An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity

Billon C, Appourchaux K, Côté I et al

J Pharmacol Exp TherAnimal

Orally active ERR agonist SLU-PP-915 enhances aerobic exercise capacity in mice with exercise mimetic activity

Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney

Wang XX, Myakala K, Libby AE et al

Am J PatholAnimal

ERR agonist reversed age-related kidney dysfunction, albuminuria, and inflammation in aging mice

In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential

In Vitro · Rapid Commun Mass Spectrom

Characterized metabolites of pan-ERR agonists SLU-PP-332 and SLU-PP-915 using LC-HRMS/MS

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapies have not been evaluated by the FDA for most listed indications.All prices shown are estimates based on publicly available data and may not reflect current pricing — providers and brands set their own prices and can change them at any time. Always verify pricing directly with the provider before purchasing. Consult a licensed healthcare provider before starting any peptide protocol.

Ready to explore Slu-Pp-332 with a provider?

Take our 2-minute quiz to get matched with a board-certified provider specializing in Slu-Pp-332.

Take the Quiz →